World's Best Scientists 2026 revealed!
Hans Wildiers

Hans Wildiers

D-Index & Metrics

Medicine

D-Index
84
Citations
32196
World Ranking
14926
National Ranking
188

Overview

Hans Wildiers is affiliated with KU Leuven in Belgium and has a significant body of research primarily in the fields of medicine, biochemistry, genetics, and molecular biology. Their academic work spans multiple subfields, including oncology, pulmonary and respiratory medicine, cancer research, radiology and nuclear medicine, and genetics.

The research focus covers diverse topics such as advanced breast cancer therapies, breast cancer treatment studies, cancer treatment and pharmacology, HER2/EGFR in cancer research, frailty in older adults, cancer immunotherapy and biomarkers, and cancer genomics and diagnostics.

Frequent coauthors in Hans Wildiers' scientific collaborations include:

  • Patrick Neven
  • Kevin Punie
  • Giuseppe Floris
  • Ann Smeets
  • Christine Desmedt

Hans Wildiers has published extensively in several scientific venues, with a large number of contributions appearing in:

  • Cancer Research
  • Annals of Oncology
  • Journal of Geriatric Oncology
  • Journal of Clinical Oncology
  • ESMO Open

Among recent papers, notable publications include:

  • "A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer" (2021, Nature Medicine)
  • "Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial" (2020, Journal of Clinical Oncology)
  • "Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial" (2020, The Lancet Oncology)
  • "Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)" (2021, The Lancet Oncology)
  • "Cancer and Aging: Two Tightly Interconnected Biological Processes" (2021, Cancers)

Best Publications

  • Vascular Endothelial Growth Factor and Angiogenesis

    Ann Hoeben;Bart Landuyt;Martin S. Highley;Hans Wildiers

  • International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer

    Hans Wildiers;Pieter Heeren;Martine Puts;Eva Topinkova

  • Association analysis identifies 65 new breast cancer risk loci

    Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley

  • Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

    Nasim Mavaddat;Kyriaki Michailidou;Kyriaki Michailidou;Joe Dennis;Michael Lush

  • Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

    Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch

  • Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations

    L Decoster;K Van Puyvelde;S Mohile;U Wedding

  • Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial

    Ian E Krop;Sung-Bae Kim;Antonio González-Martín;Patricia M LoRusso

  • Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)

    Laura Biganzoli;Hans Wildiers;Catherine Oakman;Lorenza Marotti

  • Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

    Kyriaki Michailidou;Jonathan Beesley;Sara Lindstrom;Sander Canisius

  • Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

    Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley

  • Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

    Nasim Mavaddat;Paul D.P. Pharoah;Kyriaki Michailidou;Jonathan Tyrer

  • MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

    Maura N. Dickler;Sara Tolaney;Hope S. Rugo;Javier Cortés

  • Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial

    Ian E Krop;Sung-Bae Kim;Antonio Gonzalez Martin;Patricia M LoRusso

  • A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer

    Ayse Bassez;Hanne Vos;Laurien Van Dyck;Giuseppe Floris

  • Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With >= 2 HER2-Directed Regimens: Phase III NALA Trial

    Cristina Saura;Mafalda Oliveira;Yin-Hsun Feng;Ming-Shen Dai

  • Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study.

    Pace participants;R A Audisio;D Pope;H S J Ramesh

  • Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial

    Sara A. Hurvitz;Miguel Martin;W. Fraser Symmans;Kyung Hae Jung

  • Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology

    Hans Wildiers;Ian Kunkler;Laura Biganzoli;Jacques Fracheboud

  • Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11.

    H Wildiers;G Guetens;G De Boeck;E Verbeken

  • Performance of Two Geriatric Screening Tools in Older Patients With Cancer

    Cindy Kenis;Lore Decoster;Katrien Van Puyvelde;Jacques De Grève

Frequent Co-Authors

Patrick Neven
Patrick Neven KU Leuven
Graham G. Giles
Graham G. Giles University of Melbourne
Peter A. Fasching
Peter A. Fasching University of Erlangen-Nuremberg
Hiltrud Brauch
Hiltrud Brauch German Cancer Research Center
Vessela N. Kristensen
Vessela N. Kristensen Oslo University Hospital
Roger L. Milne
Roger L. Milne Cancer Council Victoria
Jenny Chang-Claude
Jenny Chang-Claude German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in Medicine in the USA opens up a variety of online degree options and progressive career pathways. For registered nurses aiming to become nurse practitioners, flexible adn to np bridge programs are designed to help you advance while balancing work commitments.

Those interested in preventive health and dietary wellness can explore online nutrition degrees, which provide specialized knowledge in food sciences and nutrition without the need for traditional on-campus study.

For those seeking leadership roles in healthcare, enrolling in top cahme accredited mha programs offers advanced training in healthcare administration and management—ideal for future hospital and healthcare system executives.

Nurses looking for academic advancement with flexible requirements may consider rn to bsn no clinical hours programs, which allow for degree completion online without additional in-person clinicals.

These online pathways make it easier for individuals at all stages of their medical careers to grow, specialize, and contribute to the evolving world of healthcare.

Best Scientists Citing Hans Wildiers

Trending Scientists